Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial and viral surface components encompass a broad array of molecular structures located on the exterior of pathogens, including peptidoglycans, lipopolysaccharides, and viral envelope glycoproteins. These structures are essential for the pathogen's structural integrity, environmental resistance, and the ability to adhere to and invade host cells. For instance, bacterial cell walls provide osmotic protection, while viral surface proteins like the SARS-CoV-2 spike protein facilitate membrane fusion and entry into human respiratory cells [1, 2]. These components are frequently recognized by the host's innate immune system as Pathogen-Associated Molecular Patterns (PAMPs) through Pattern Recognition Receptors (PRRs) [4]. In pharmacology, these surface components serve as the primary targets for many anti-infective agents. Antibiotics such as beta-lactams inhibit the synthesis of the bacterial peptidoglycan layer, leading to cell lysis, while monoclonal antibodies target specific viral surface antigens to neutralize the virus before it can infect host cells [1, 2]. Additionally, many vaccines are designed to elicit an immune response against these surface molecules to provide long-term protection. However, the high rate of mutation in viral surface proteins and the development of modified bacterial cell wall structures present significant challenges, often leading to drug resistance and the requirement for seasonal vaccine updates [3, 4]. Sources: [1] Sizar O, et al. "Gram Positive Bacteria." StatPearls. 2023. [2] Huang Y, et al. "Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19." Acta Pharmaceutica Sinica B. 2020. [3] Farhana A, Khan YS. "Biochemistry, Lipopolysaccharide." StatPearls. 2023. [4] Mogensen TH. "Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses." Clinical Microbiology Reviews. 2009.
Inhibition of cell wall synthesis, neutralization of viral entry, disruption of membrane integrity, and opsonization for immune clearance.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial and viral surface components.